2019 Archives

Cuba advances HIV/AIDS vaccine project 

CGTN | December 21, 2019

Estimation of new HIV diagnosis rates among high-risk, PrEP-eligible individuals using HIV surveillance data at the Metropolitan Statistical Area level in the United States

Journal of the International AIDS Society | December 20, 2019

How Close Are We to Curing HIV? 

IDSE.net | December 13, 2019

Unsung heroes: Pittsburgh men, decades-long study impact HIV/AIDS research 

TribLIVE | December 15, 2019

Vesicles released by bacteria may reduce the spread of HIV in human tissue

NIH | December 11, 2019

Gay, bisexual men increasingly agree: HIV “Undetectable Equals Untransmittable”

NIH | December 5, 2019

Preventive HIV vaccine Enters Phase 3 Global Study

IAS 2019: Conference on HIV Pathogenesis Treatment and Prevention Mexico City July 21-24 2019

The Future—And the End?—of AIDS 

Columbia University Irving Medical Center | November 27, 2019

ViiV Healthcare announces exclusive licensing agreement with the National Institutes of Health for investigational “bNAb” with potential for long-acting HIV treatment and prevention

ViiV | November 21, 2019

Colonic microbiota exhibits disparate associations with HIV infection and sexual practices

21st International Workshop n Co-morbidities and Adverse Drug Reactions in HIV

Only 1% HIV Diagnosis Rate More Than 6 Months After PEP in 975 People

17th European AIDS Conference, November 6-9, 2019, Basel

Maryland Medical Company Claims To Have Cure For HIV, AIDS 

CBS Pittsburgh | November 8, 2019

First New HIV Strain in 19 Years Identified 

Scientific American | November 6, 2019

Researchers adapt CAR-T immunotherapy to target the HIV latent reservoir 

Medical Xpress | October 24, 2019

NIH Launches New Collaboration to Develop Gene-Based Cures for Sickle Cell Disease and HIV on Global Scale

HIV.gov | October 24, 2019

The Future of ARV-Based Prevention and More

AVAC.org | October 23, 2019

NIH launches new collaboration to develop gene-based cures for sickle cell disease and HIV on global scale

NIH | October 23, 2019

Drug reverses signs of liver disease in people living with HIV

NIH | October 15, 2019

The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy

AIDS Res Hum Retroviruses. 2019 Oct 14. doi: 10.1089/AID.2019.0175

Study demonstrates antibody responses within 6 weeks of initial vaccination 

EurekAlert | October 1, 2019

AIDS Treatment: Russian Researchers Create New Medications 

QS WOW News | September 29, 2019

UAB researchers land funding to combat HIV 

Birmingham Business Journal | September 27, 2019

UC San Diego Researchers Isolate Switch that Kills Inactive HIV 

UC San Diego Health | September 24, 2019

Papillomaviruses May Be Able To Be Spread By Blood

EurekAlert | September 11, 2019

CRISPR shown to be safe to target HIV (but unsuccessful so far) 

The Daily Briefing | September 13, 2019

An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals

Science Translational Medicine | September 7, 2019

The disconnect between individual-level and population-level HIV prevention benefits of antiretroviral treatment 

The Lancet | September 2019

Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities 

The Lancet | September 2019

Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States.

Clin Infect Dis. 2018 Jan 6;66(2):213-219. doi: 10.1093/cid/cix755.

Cellular therapies are the next big step in fight against HIV/Aids 

Independent Online | August 31, 2019

Animal activists are on the wrong side of the fight against AIDS 

STAT | August 30, 2019

Arrowhead Collaborator Janssen Begins REEF-1 Phase 2b Combination Study in Patients with Chronic Hepatitis B Infection

BusinessWire | August 28, 2019

Repeated semen exposure promotes host resistance to infection in preclinical HIV model 

EurekAlert | August 21, 2019

New Molecule Identified That May Further Suppress Effectively Treated HIV

POZ | August 14, 2019

Cancer therapy returns to original target: HIV 

Science Magazine | August 9, 2019

HOPE trial: Dapivirine vaginal ring reduces HIV risk by estimated 39% 

Healio | August 6, 2019

Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV

JCI | July 22, 2019

Johnson & Johnson Announces New Public-Private Partnership to Support First Phase 3 Efficacy Study of Janssen’s Investigational Prophylactic HIV Vaccine

IAS 2019: Conference on HIV Pathogenesis Treatment and Prevention, Mexico City, July 21-24 2019

PrEP use high but wanes after three months among young African women

NIH | July 23, 2019

Developing a novel HIV vaccine: DNA and recombinant proteins 

Science Daily | July 23, 2019

Duke Human Vaccine Institute receives $129 million grant for HIV/AIDS research 

Duke Chronicle | July 19, 2019

HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa

New England Journal of Medicine | July 18, 2019

Effect of Universal Testing and Treatment on HIV Incidence — HPTN 071 (PopART)

New England Journal of Medicine | July 18, 2019

Universal Testing, Expanded Treatment, and Incidence of HIV Infection in Botswana

New England Journal of Medicine | July 18, 2019

HIV-1 Epidemic Control — Insights from Test-and-Treat Trials, Slim Abdool Karim

New England Journal of Medicine | July 18, 2019


Acceptability and Preferences for Long-Acting Antiretroviral Formulations Among People Living with HIV infection

IAPAC Adherence June 17-19 Miami

Enlisting CRISPR in the Quest for an HIV Cure

NIH | July 16th, 2019

Johnson & Johnson to start testing on new type of HIV vaccine in US and Europe 

New York Daily News | July 13, 2019

Consortium Led by Scripps Research Gets $129 Million for HIV/AIDS Vaccine Clinical Trials 

Times of San Diego | July 10, 2019

HIV-1 self-testing to improve the efficiency of pre-exposure prophylaxis delivery: a randomized trial in Kenya

Trials. 2019 Jul 4;20(1):396. doi: 10.1186/s13063-019-3521-2.

HIV eliminated from the genomes of living animals

Nature Communications | June 2019

Genotype Testing at HIV Diagnosis Provides No Benefit 

Infectious Disease Advisor | June 24, 2019

Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection

Science Translational Medicine | June 15, 2019

AIDSinfo Updates Investigational HIV Drug Fact Sheets

AIDSinfo | June 14, 2019

Women and Clinical Trials

The New York Times | June 14, 2019

GSK partners with CRISPR pioneer Doudna to search for new drugs

STAT News | June 13, 2019

Durable Control of HIV Infection in the Absence of Antiretroviral Therapy - Opportunities and Obstacles

Viewpoint | June 6, 2019

Trump administration imposes new restrictions on fetal tissue research

Washington Post | June 5, 2019

Statement from the Department of Health and Human Services

HHS.gov | June 5, 2019

Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer—A Phase 1 Study

JAMA Oncol. Published online June 2, 2019

HIV Vaccine Awareness Day 2019 — May 18, 2019

National Institutes of Health | May 17, 2019

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from ...

Yahoo Finance | May 13, 2019

NIH Trial Evaluates Long-acting HIV Medication Unable to Adhere to Strict Daily Regimens - LATITUDE study compares monthly injectable antiretroviral therapy to daily oral drugs

NIH | May 9, 2019

NIH awards will advance development of vaccines for sexually transmitted infections

NIH | May 5, 2019

Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base

Cancer. 2019 May 3. doi: 10.1002/cncr.32158

Boston hospital receives largest philanthropic gift in history for HIV/AIDS vaccine research

WCVB Boston | April 25, 2019

Novel antibody may suppress HIV for up to four months

NIH | April 17, 2019

Scientists find another way HIV can hide from vaccines

Yale News | April 10, 2019

Orion Biotechnology to Present OB-002 in Vitro Potency Data at the 10th International AIDS Society HIV Science Meeting in Mexico City in July 2019

PR Newswire | March 28, 2019

Aaron Diamond AIDS Research Center to Join Columbia University

Columbia University | March 20, 2019

Curing HIV just got more complicated. Can CRISPR help?

Science Magazine | March 15, 2019

Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach

PLoS Med. 2019 Mar 4;16(3):e1002756. doi: 10.1371/journal.pmed.1002756. eCollection 2019 Mar.

This is Not A Cure for My H.I.V.

New York Times | March 9, 2019

One step closer to ultra-long-acting PREP?

AIDS: march 2019

New Target for HIV Immune Therapy and Cure to be Explored by Trans-Atlantic Industry-Academia Collaboration

NATAP | February 20th, 2019

Unintended HIV-1 Transmission to a Sex Partner in a Study of a Therapeutic Vaccine Candidate

HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge

Nat Commun. 2019 Feb 18;10(1):798. doi: 10.1038/s41467-019-08739-4

NIH Clinical Trial to Track Outcomes of Liver Transplantation from HIV-Positive Donors to HIV-Positive Recipients

HIV.gov | February 15, 2019

Ending the HIV Epidemic: A Plan for the United States

NIH | February 7, 2019

Study of PrEP and vaginal ring for HIV prevention begins in girls and young women

NIH | February 7, 2019

HIV-AIDS drug could help treat Alzheimer's and other age-related diseases, Brown researchers say

The Providence Journal | February 6, 2019

Hodgkin's lymphoma and its association with EBV and HIV infection

Crit Rev Clin Lab Sci. 2018 Mar;55(2):102-114. doi: 10.1080/10408363.2017.1422692. Epub 2018 Jan 9

Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer

A Systematic Review

Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028-study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation

BMJ Open. 2019 Jan 17;9(1):e024793. doi: 10.1136/bmjopen-2018-024793.

Heterosexual oral and anal sex in Kinshasa (D.R.Congo): Data from OKAPI prospective cohort

PLoS One. 2019 Jan 16;14(1):e0210398. doi: 10.1371/journal.pone.0210398. eCollection 2019

Incidence and Correlates of STIs among Black Men who have Sex with Men Participating in the HPTN 073 PrEP Study.

Clin Infect Dis. 2019 Jan 7. doi: 10.1093/cid/ciy1141.

Scientists achieve the first proof of concept for an HIV broadly-neutralising antibody vaccine in ...

aidsmap | January 2, 2019